Literature DB >> 7655030

Prevalence of heterozygotes for hemochromatosis in the white population of the United States.

C E McLaren1, V R Gordeuk, A C Looker, V Hasselblad, C Q Edwards, L M Griffen, J P Kushner, G M Brittenham.   

Abstract

In previous studies, the prevalence of HLA-linked hemochromatosis, thought to be the most common genetic illness in whites, has been estimated by identifying homozygotes in the population. Because not all homozygotes express the disease phenotypically, the accuracy of these estimates is uncertain. We analyzed the distribution of transferrin saturation values in the second National Health and Nutrition Examination Survey to estimate the prevalence of hemochromatosis heterozygotes in the US population. After removing values for possible homozygotes, two populations were present (P < .01 for each gender). When weighted to reflect the US adult white male population as a whole, a proportion of 850 per 1,000 (95% confidence interval, 0.81 to 0.89) were included in a population with a lower mean saturation of 29.7% (29.1% to 30.3%), whereas 150 per 1,000 (0.11 to 0.19) comprised a population with a higher mean saturation of 47.0% (45.1% to 49.0%). Similar results were found for the female population. The gene frequencies were estimated to be 0.081 from the male population and 0.070 from the female population corresponding to prevalences of homozygotes of 6.6 and 4.8 per 1,000, respectively. Our results confirm that the gene for hemochromatosis is common.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7655030

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  12 in total

1.  Homozygosity for the predominant Cys282Tyr mutation and absence of disease expression in hereditary haemochromatosis.

Authors:  D A Rhodes; R Raha-Chowdhury; T M Cox; J Trowsdale
Journal:  J Med Genet       Date:  1997-09       Impact factor: 6.318

2.  An unusual case of hemochromatosis in an African-American man: case report and review of the literature.

Authors:  David A Labowitz; Jennifer Bontreger; Albert D Min
Journal:  Dig Dis Sci       Date:  2007-04-10       Impact factor: 3.199

3.  The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding.

Authors:  J N Feder; D M Penny; A Irrinki; V K Lee; J A Lebrón; N Watson; Z Tsuchihashi; E Sigal; P J Bjorkman; R C Schatzman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

Review 4.  The hereditary hemochromatosis gene (HFE): a MHC class I-like gene that functions in the regulation of iron homeostasis.

Authors:  J N Feder
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

Review 5.  Population screening for hemochromatosis: has the time finally come?

Authors:  J C Barton; R T Acton
Journal:  Curr Gastroenterol Rep       Date:  2000-02

6.  Simultaneous detection of C282Y and H63D hemochromatosis mutations by dual-color probes.

Authors:  M Phillips; C A Meadows; M Y Huang; A Millson; E Lyon
Journal:  Mol Diagn       Date:  2000-06

7.  Exome sequencing in HFE C282Y homozygous men with extreme phenotypes identifies a GNPAT variant associated with severe iron overload.

Authors:  Christine E McLaren; Mary J Emond; V Nathan Subramaniam; Pradyumna D Phatak; James C Barton; Paul C Adams; Justin B Goh; Cameron J McDonald; Lawrie W Powell; Lyle C Gurrin; Katrina J Allen; Deborah A Nickerson; Tin Louie; Grant A Ramm; Gregory J Anderson; Gordon D McLaren
Journal:  Hepatology       Date:  2015-03-18       Impact factor: 17.425

8.  Red ginseng abrogates oxidative stress via mitochondria protection mediated by LKB1-AMPK pathway.

Authors:  Guang-Zhi Dong; Eun Jeong Jang; Seung Ho Kang; Il Je Cho; Sun-Dong Park; Sang Chan Kim; Young Woo Kim
Journal:  BMC Complement Altern Med       Date:  2013-03-18       Impact factor: 3.659

9.  Homogeneous multiplex genotyping of hemochromatosis mutations with fluorescent hybridization probes.

Authors:  P S Bernard; R S Ajioka; J P Kushner; C T Wittwer
Journal:  Am J Pathol       Date:  1998-10       Impact factor: 4.307

10.  HFE C282Y and H63D in adults with malignancies in a community medical oncology practice.

Authors:  James C Barton; Luigi F Bertoli; Ronald T Acton
Journal:  BMC Cancer       Date:  2004-02-10       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.